HIMS Hims & Hers Health
- 12.500
- +0.230+1.87%
- 12.690
- +0.190+1.52%
Hims & Hers Health News
Institutional Investors Must Be Pleased After a 5.0% Gain Last Week That Adds to Hims & Hers Health, Inc.'s (NYSE:HIMS) One-year Returns
Key Insights Institutions' substantial holdings in Hims & Hers Health implies that they have significant influence over the company's share price A total of 15 investors have a majority stake in the
Hims & Hers Health Adds New Independent Director
Seaport Global Starts Hims & Hers Health With Buy Rating
Hims & Hers Health (HIMS) has an average rating of outperform and price targets ranging from $7 to $20, according to analysts polled by Capital IQ. Price: 12.42, Change: +0.15, Percent Change: +1.22
Express News | NYSE Order Imbalance 132698.0 Shares on Sell Side
Zacks Investment Ideas Feature Highlights: Hims & Hers Health, Coinbase Global
Express News | NYSE Order Imbalance 117561.0 Shares on Sell Side 117561.0 Shares on Sell Side
Hims & Hers Health, Inc. (HIMS) Suffers a Larger Drop Than the General Market: Key Insights
Express News | NYSE Order Imbalance 91472.0 Shares on Sell Side 91472.0 Shares on Sell Side
Hims & Hers Health(HIMS.US) Officer Sells US$34,916.85 in Common Stock
$Hims & Hers Health(HIMS.US)$ Officer Boughton Soleil sold 2,503 shares of common stock on Apr 15, 2024 at an average price of $13.95 for a total value of $34,916.85.Source: Announcement What is state
Express News | NYSE Order Imbalance 62225.0 Shares on Buy Side
Express News | Hims & Hers Health Shares Are Trading Lower After Jefferies Downgraded the Stock From Buy to Hold
Express News | Hims & Hers Health Shares Down 3.5% Premarket After Jefferies Cuts to Hold From Buy
Express News | Hims & Hers Health Inc : Jefferies Cuts Target Price to $15 From $17
Hims & Hers to Announce First Quarter 2024 Financial Results on May 6, 2024
Hims & Hers Health, Inc. ((", Hims &, Hers, ", NYSE:HIMS), the leading health and wellness platform, today announced that it will report first quarter 2024 financial results after the market closes on
Express News | NYSE Order Imbalance 88145.0 Shares on Sell Side
Express News | NYSE Order Imbalance 220773.0 Shares on Buy Side
Express News | NYSE Order Imbalance 72514.0 Shares on Sell Side
Breaking Down Hims & Hers Health: 6 Analysts Share Their Views
In the preceding three months, 6 analysts have released ratings for Hims & Hers Health (NYSE:HIMS), presenting a wide array of perspectives from bullish to bearish.The table below summarizes their rec
Hims & Hers Health Initiated at Buy by Canaccord Genuity
Hims & Hers Health Initiated at Buy by Canaccord Genuity
Express News | Canaccord Genuity Initiates Coverage On Hims & Hers Health With Buy Rating, Announces Price Target of $20
Analysis
Price Target
No Data
